您好,欢迎访问三七文档
当前位置:首页 > 医学/心理学 > 药学 > 晚期非小细胞肺癌、乳腺癌的一线治疗药物
®VinorelbineBitartrateInjection1®(Vinorelbine,NVB)1974Potier199327199412FDANSCLC40NSCLC3-510%-15%3-51ml:10mg28,20241/12H200677222005500000330000170000NSCLC80NSCLCNSCLC50342001-20052005149.78,14.802040608010012014016000.050.10.150.20.250.383.9294.86109.64130.47149.7813.04%15.58%19.00%14.80%200120022003200420052®NSCLC¾¾2006ASCO+NSCLC¾200620053.172.68®2006®VCR0.5RNA®1.8m21ml:10mg25-30mg/m25-645-54mg2-410-2420200-480200631.8m21ml:10mg25-30mg/m25-645-54mg2-410-24101ml:10mg100-24027®1zzzG2DNAz2NSCLC14-33%50%40-60%30%74%HMM35%570%85%55%3125ml15-204VNLB31.3%VNLB+DDP33%VNLP+DDP+Vp-1642-45%VNLB+DDP63.4%VNLB+AMD77%VNLB+Methyl-GAG80.7%4VNLB+|IFO+Vp-1680.7%VNLB+5-FU+CDDP33.3%VNLB+44%VNLB+80%1IV30mg/m21880mg/m212IV25mg/m2181000mg/m2183525-30mg/m21000mg/m21836611WHONSCLCSCLCNSCLC8010513NSCLC2/3NSCLS2(NSCLC)(SCLC)(NSCLC)(SCLC)IIIA532006ASCO+NSCLC®999999
本文标题:晚期非小细胞肺癌、乳腺癌的一线治疗药物
链接地址:https://www.777doc.com/doc-364837 .html